¿Es efectivo y seguro el uso de patiromer para el control de la hiperpotasemia en pacientes con hipertensión resistente y enfermedad renal crónica en tratamiento con espironolactona (ensayo AMBER)?
Read
5418
Timeswas read the article
2941
Total PDF
2477
Total HTML
Article information
ISSN: 18889700Original language: Spanish
The statistics are updated each day
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 38 | 14 | 52 |
| 2025 5 | 96 | 42 | 138 |
| 2025 4 | 71 | 33 | 104 |
| 2025 3 | 65 | 49 | 114 |
| 2025 2 | 80 | 35 | 115 |
| 2025 1 | 84 | 53 | 137 |
| 2024 12 | 36 | 35 | 71 |
| 2024 11 | 64 | 79 | 143 |
| 2024 10 | 54 | 44 | 98 |
| 2024 9 | 45 | 35 | 80 |
| 2024 8 | 64 | 80 | 144 |
| 2024 7 | 42 | 48 | 90 |
| 2024 6 | 56 | 42 | 98 |
| 2024 5 | 45 | 55 | 100 |
| 2024 4 | 49 | 45 | 94 |
| 2024 3 | 77 | 37 | 114 |
| 2024 2 | 57 | 47 | 104 |
| 2024 1 | 42 | 34 | 76 |
| 2023 12 | 29 | 32 | 61 |
| 2023 11 | 24 | 26 | 50 |
| 2023 10 | 36 | 38 | 74 |
| 2023 9 | 24 | 38 | 62 |
| 2023 8 | 29 | 40 | 69 |
| 2023 7 | 42 | 48 | 90 |
| 2023 6 | 48 | 35 | 83 |
| 2023 5 | 57 | 40 | 97 |
| 2023 4 | 36 | 29 | 65 |
| 2023 3 | 21 | 21 | 42 |
| 2023 2 | 26 | 26 | 52 |
| 2023 1 | 29 | 26 | 55 |
| 2022 12 | 30 | 32 | 62 |
| 2022 11 | 41 | 33 | 74 |
| 2022 10 | 30 | 54 | 84 |
| 2022 9 | 39 | 43 | 82 |
| 2022 8 | 30 | 47 | 77 |
| 2022 7 | 35 | 55 | 90 |
| 2022 6 | 32 | 39 | 71 |
| 2022 5 | 35 | 54 | 89 |
| 2022 4 | 44 | 60 | 104 |
| 2022 3 | 55 | 96 | 151 |
| 2022 2 | 47 | 55 | 102 |
| 2022 1 | 40 | 89 | 129 |
| 2021 12 | 43 | 70 | 113 |
| 2021 11 | 43 | 94 | 137 |
| 2021 10 | 37 | 116 | 153 |
| 2021 9 | 52 | 66 | 118 |
| 2021 8 | 30 | 64 | 94 |
| 2021 7 | 29 | 64 | 93 |
| 2021 6 | 37 | 73 | 110 |
| 2021 5 | 39 | 79 | 118 |
| 2021 4 | 80 | 135 | 215 |
| 2021 3 | 45 | 77 | 122 |
| 2021 2 | 49 | 67 | 116 |
| 2021 1 | 22 | 60 | 82 |
| 2020 12 | 32 | 59 | 91 |
| 2020 11 | 14 | 39 | 53 |
| 2020 10 | 1 | 15 | 16 |
Show all
